Related Experiment Video
Updated: May 27, 2025

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Structure and function of MDM2 and MDM4 in health and disease
Ivy Yiyi Zhu1, Alec Lloyd1, William R Critchley1
1School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K.
Abstract:
Both mouse double-minute 2 (MDM2), an E3 ubiquitin ligase, and its closely related paralog, MDM4, which lacks E3 activity, play central roles in cellular homeostasis. MDM-linked dysfunction is associated with an increased risk of oncogenesis, primarily through targeting the tumor suppressor protein p53 for ubiquitination and degradation. Recent studies have revealed multifaceted roles of MDM proteins that are p53 independent with implications for their oncogenic properties. This review aims to provide an overview of MDM2 and MDM4, by assessing gene and protein structure and implications for protein-protein interactions and functions in cell and animal physiology. We also explore MDM2 and MDM4 role(s) in angiogenesis, a critical feature of solid tumor growth and progression. Finally, we discuss the current landscape in the development of MDM2 and MDM4 inhibitors for cancer therapy.
Insights
Mouse double-minute 2 (MDM2) and MDM4 proteins regulate cellular homeostasis and are implicated in cancer development. This review covers their roles, p53-independent functions, and therapeutic inhibition strategies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Mouse double-minute 2 (MDM2) and MDM4 are crucial regulators of cellular homeostasis.
- Dysfunction of MDM proteins is linked to oncogenesis, often via the tumor suppressor p53.
- Emerging evidence highlights p53-independent roles of MDM proteins in cancer.
Purpose of the Study:
- To provide a comprehensive overview of MDM2 and MDM4.
- To assess their gene and protein structure, interactions, and physiological functions.
- To explore their roles in angiogenesis and discuss therapeutic inhibitor development.
Main Methods:
- Literature review and analysis of existing studies on MDM2 and MDM4.
- Assessment of gene and protein structures and their functional implications.
- Examination of roles in angiogenesis and current therapeutic strategies.
Main Results:
- MDM2 and MDM4 are key regulators of p53, a critical tumor suppressor.
- MDM proteins exhibit p53-independent functions contributing to oncogenesis.
- MDM2 and MDM4 play significant roles in angiogenesis, vital for tumor growth.
Conclusions:
- MDM2 and MDM4 are central to cellular homeostasis and oncogenesis.
- Understanding their p53-dependent and independent functions is critical for cancer research.
- Targeting MDM2 and MDM4 presents a promising avenue for novel cancer therapies.
Related Concept Videos
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Master Transcription Regulators
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

